# Infertility Challenge in a Cryptozoospermic Patient With Y Chromosome Microdeletion

## TL;DR

The paper discusses infertility in a man with a Y chromosome microdeletion and explores treatment options like intracytoplasmic sperm injection.

## Contribution

The study highlights the role of Y chromosome AZFc microdeletion in male infertility and its hormonal implications.

## Key findings

- Y chromosome microdeletions in AZFa, AZFb, and AZFc regions are linked to oligozoospermia or azoospermia.
- AZFc microdeletion may cause endocrine hormone irregularities affecting sperm production.
- Intracytoplasmic sperm injection is a primary treatment for azoospermic and cryptozoospermic patients.

## Abstract

A couple is usually diagnosed with infertility if they have regular, unprotected sexual activity for a year or longer and are unable to conceive. Male infertility can be categorised into three types: obstructive infertility, non-obstructive infertility, and coital infertility. A major contributing factor for infertility in men is Y chromosome microdeletion, which is a non-obstructive infertility that involves problems related to sperm production. Deletions in the azoospermia factor region known as azoospermia factor a (AZFa), azoospermia factor b (AZFb), and azoospermia factor c (AZFc) loci independently or together which are situated on the Y chromosome cause a disturbance and alteration that are linked to either a reduction in sperm count, known as oligozoospermia, or the absence of sperm cells in the semen sample, referred to as azoospermia. Observations indicate that individuals with AZFc microdeletion may display irregularities in endocrine hormones. Men experiencing hormonal abnormalities affecting sperm production may receive treatment with clomiphene citrate. In cases of azoospermia and numerous cryptozoospermic patients, intracytoplasmic sperm injection is frequently considered the primary therapeutic approach.